Numedii, Inc.

Numedii, Inc.

Numedii, Inc.

Overview
Date Founded

2008

Headquarters

66 Bovet Road,Suite 320,San Mateo, CA 94402

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Other Business & Consulting Services
Pharmaceuticals
Medical Support Services
Biotechnology
Holding Companies

Company Description

NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA.

Executives & Employees

Founder

Chief Scientific Officer

Vice President, Corporate Development

Chief Financial Officer

Chief Technology Officer

Board of Directors

Venture Partner at Claremont Creek Ventures

Chief Medical Officer at Protagonist Therapeutics, Inc.

President & Chief Executive Officer at Turning Point Therapeutics, Inc.

Executive Director of Clinical Informatics, Health Sciences & Services at University of California - San Francisco

Venture Partner at Claremont Creek Ventures

Founder at Numedii, Inc.

Co-Founder at Lightspeed Management Co. LLC

Paths to Numedii, Inc.
Potential Connections via
Relationship Science
You
Numedii, Inc.
Investors
Details Hidden

Stanford University (Venture Capital) invests in companies operating in the fields of medtech, edtech, consumer internet, enterprise, mobile, hardware, biotechnology, social enterprise and other industries. It provides financing for seed and early stage capital requirements. It takes minority interests and also makes co-investments.

Details Hidden

Lightspeed Management Co. is an active manager focuses on early and expansion stage investments in the US, China, India and Israel, sectors in which they invests in enterprise, consumer and energy. It is typically the first institutional investor in their portfolio companies and acts as lead investor.

Details Hidden

Claremont Creek Partners (CCP) invests in early-stage information technology companies. The firm is particularly interested in the following areas: (1) mobility including voice, data and converging platforms that facilitate collaboration in non-hierarchical, widely distributed organizations (2) healthcare including research and clinical information technology applications such as instrumentation, patient management systems and bio-informatics (3) energy efficiency including capital efficient technologies that relate to energy efficiency retrofits, monitoring and controls and platforms that improve the delivery of energy-related services and (4) security including both the digital and physical systems that comprise mobile, small business and enterprise computing environment. CCP is also interested in investments in other developing areas including VoIP, alternative energy, payment processing and distributive workforce collaboration. The firm places special emphasis on opportunities located beyond Silicon Valley. They invest in early-stage companies that have typically already received angel funding but have not yet participated in a traditional first round of venture finance. Investments generally range from $500,000 to $3 million with the potential for follow-on investments.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Numedii, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Numedii, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Numedii, Inc..